|
|
 |
|
Viewing report
|
|
|
|
Outsourcing Clinical Development
Ashgate Publishing, Feb 2006, Pages: 192
The challenges facing large pharmaceutical companies are stark: sales are slowing, and research and development costs are rising. There is an overwhelming need to reduce development costs by as much as 30-40%, while at the same time significantly shortening development cycle times.
Pharmaceutical spend on outsourcing faces double-digit growth for the next three to five years and yet, if outsourcing is to meet these challenges, new models of collaborative and cooperative working are needed now.
Outsourcing Clinical Development offers a guide to these new models and to future clinical outsourcing strategy. There is advice on the basis for an outsourcing strategy and guidance on how to work most productively with CROs (contract research organisations); geographical issues, including working in low-cost environments, are also covered. There is a detailed guide to selecting candidates, and managing the proposal, negotiation and contract process successfully; as well as reviewing outsourcing performance and developing fruitful long-term strategic relationships.
The pharmaceutical outsourcing process is as complex and as influential as the clinical trials it supports. Outsourcing Clinical Development, with a powerful mix of perceptive insight from leading lights in the industry, advice on long-term strategic direction and tools for immediate help is a must-have read for pharmaceutical companies and their CRO partners.
Customers who bought this item also bought
Strategic Clinical Sourcing: Managing Costs and CROs
The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology
Pharmaceutical Research and Development (R&D) - Increasing Efficiency through Information Technology and Externalization
Investigator-Initiated Trials: Building Superior IIT Capabilities
Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs
Strategies for Effective Partnerships Between Pharmaceutical and Diagnostic Companies
China: The Key Pharmemerging Market - Deciphering Major Pharma Companies’ China Strategy
Streamlining Clinical Trials
Drug Discovery Collaborations between Academia and the Pharmaceutical Industry: Cultural Factors, Intellectual Property Considerations, Case Studies, and Future Trends
Pharmaceutical Business Development and Licensing: Strengthening Pipelines and Managing Relationships
|
|
|
|
